Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangita M Baxi

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Cancer Drug Targets|January 10, 2013
Targeting the mTOR pathway in tumor malignancyHengmiao Cheng, Marlena Walls, Sangita M Baxi, et al.
Globalization and Health|September 20, 2019
A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medicationsSangita M Baxi, Reed Beall, Joshua Yang, et al.
Plos One|May 3, 2013
miR-221 promotes tumorigenesis in human triple negative breast cancer cellsRounak Nassirpour, Pramod P Mehta, Sangita M Baxi, et al.
Plos One|November 3, 2012
Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cellsSangita M Baxi, Wei Tan, Sean T Murphy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 22, 2007
Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigsRobert D McBane, Robert J Leadley, Sangita M Baxi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2011
Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90Pramod P Mehta, Pamela Whalen, Sangita M Baxi, et al.
AJOG Global Reports|June 15, 2026
Tranexamic acid use for the prevention of postpartum hemorrhage in high-income countries: a review of recent literatureSangita M Baxi, Irogue I Igbinosa, Elliott K Main, et al.
Journal of General Internal Medicine|September 6, 2019
Impact of Project ECHO Models of Medical Tele-Education: a Systematic ReviewRyan K McBain, Jessica L Sousa, Adam J Rose, et al.
Rand Health Quarterly|July 15, 2022
New York State 1115 Demonstration Independent Evaluation: Interim ReportHarry H Liu, Andrew W Dick, Nabeel Qureshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2013
Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216Marlena Walls, Sangita M Baxi, Pramod P Mehta, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Cancer Drug Targets|January 10, 2013
Targeting the mTOR pathway in tumor malignancyHengmiao Cheng, Marlena Walls, Sangita M Baxi, et al.
Globalization and Health|September 20, 2019
A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medicationsSangita M Baxi, Reed Beall, Joshua Yang, et al.
Plos One|May 3, 2013
miR-221 promotes tumorigenesis in human triple negative breast cancer cellsRounak Nassirpour, Pramod P Mehta, Sangita M Baxi, et al.
Plos One|November 3, 2012
Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cellsSangita M Baxi, Wei Tan, Sean T Murphy, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 22, 2007
Iliac venous stenting: antithrombotic efficacy of PD0348292, an oral direct Factor Xa inhibitor, compared with antiplatelet agents in pigsRobert D McBane, Robert J Leadley, Sangita M Baxi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2011
Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90Pramod P Mehta, Pamela Whalen, Sangita M Baxi, et al.
AJOG Global Reports|June 15, 2026
Tranexamic acid use for the prevention of postpartum hemorrhage in high-income countries: a review of recent literatureSangita M Baxi, Irogue I Igbinosa, Elliott K Main, et al.
Journal of General Internal Medicine|September 6, 2019
Impact of Project ECHO Models of Medical Tele-Education: a Systematic ReviewRyan K McBain, Jessica L Sousa, Adam J Rose, et al.
Rand Health Quarterly|July 15, 2022
New York State 1115 Demonstration Independent Evaluation: Interim ReportHarry H Liu, Andrew W Dick, Nabeel Qureshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2013
Targeting small cell lung cancer harboring PIK3CA mutation with a selective oral PI3K inhibitor PF-4989216Marlena Walls, Sangita M Baxi, Pramod P Mehta, et al.
Pageof 2